Literature DB >> 17268098

HPLC analysis of orlistat and its application to drug quality control studies.

Effat Souri1, Hassan Jalalizadeh, Abbas Kebriaee-Zadeh, Bettina Zadehvakili.   

Abstract

In this study, a high performance liquid chromatography method with UV detection was developed for determination of orlistat. The chromatographic system consisted of a Nova-Pack C18 column, an isocratic mobile phase of phosphoric acid 0.1%-acetonitrile (10 : 90, v/v) and UV detection at 205 nm. Orlistat was eluted at about 6 min with no interfering peak from excipients used for preparation of dosage form. The method was linear over the range of 10-160 microg/ml orlistat (r2 > 0.9999). The within-day and between-day precision values were also in the range of 0.10-0.59%. The appropriate dissolution conditions were also determined and applied to evaluate the dissolution profile of orlistat capsules. Optimal conditions were 1000 ml of 3% SLS in water as dissolution medium and paddle at 100 rotation per minute. The proposed method was applied successfully to the determination of orlistat content in capsules and in vitro dissolution studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268098     DOI: 10.1248/cpb.55.251

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Development and Optimization of a High-Throughput Screening Assay for Rapid Evaluation of Lipstatin Production by Streptomyces Strains.

Authors:  Michal Híreš; Nora Rapavá; Martin Šimkovič; Ľudovít Varečka; Dušan Berkeš; Svetlana Kryštofová
Journal:  Curr Microbiol       Date:  2017-12-18       Impact factor: 2.188

2.  Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo.

Authors:  Shawn Dowling; James Cox; Richard J Cenedella
Journal:  Lipids       Date:  2009-04-21       Impact factor: 1.880

3.  Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines.

Authors:  Tanner K Hill; Amanda L Davis; Frances B Wheeler; Sneha S Kelkar; Erica C Freund; W Todd Lowther; Steven J Kridel; Aaron M Mohs
Journal:  Mol Pharm       Date:  2016-02-08       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.